110 related articles for article (PubMed ID: 2177430)
1. Pharmacological properties of newly synthesized derivatives of (-)-6 beta-acetylthionormorphine and their interactions with opioid receptors.
Takayanagi I; Koike K; Suzuki T
Gen Pharmacol; 1990; 21(5):605-11. PubMed ID: 2177430
[TBL] [Abstract][Full Text] [Related]
2. Interaction of newly synthesized N-cyclopropylmethyl derivatives of (-)-6 beta-acetylthionormorphine with opioid receptors.
Takayanagi I; Goromaru N; Koike K; Konno F; Mori T; Yoshida M; Kanematsu K
Gen Pharmacol; 1990; 21(4):541-6. PubMed ID: 2165960
[TBL] [Abstract][Full Text] [Related]
3. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
[TBL] [Abstract][Full Text] [Related]
4. Interactions of N-cyclopropylmethyl(-)-6 beta-acetylthionormorphine with mu-, kappa-, delta- and sigma-opioid receptors.
Takayanagi I; Koike K; Satoh M
Gen Pharmacol; 1991; 22(5):965-7. PubMed ID: 1662176
[TBL] [Abstract][Full Text] [Related]
5. Some pharmacological properties of a newly synthesized morphine derivative, (-)-6 beta-acetylthiomorphine.
Takayanagi I; Konno F; Goromaru N; Koike K; Kanematsu K; Fujii I; Togame H
Arch Int Pharmacodyn Ther; 1988; 294():71-84. PubMed ID: 3069065
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of KT-90 using cloned mu-, delta- and kappa-opioid receptors.
Katsumata S; Ienaga Y; Minami M; Nakagawa T; Kanematsu K; Satoh M
Eur J Pharmacol; 1996 Oct; 312(3):349-55. PubMed ID: 8894618
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of the ameliorating effect on learning and memory impairment and antinociceptive effect of KT-95 in mice.
Hiramatsu M; Mizuno N; Kanematsu K
Behav Brain Res; 2006 Feb; 167(2):219-25. PubMed ID: 16223533
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of the ameliorating effect on short-term memory impairment and antinociceptive effect of KT-90 in mice.
Hiramatsu M; Hoshino T; Kanematsu K
Behav Brain Res; 2005 May; 160(2):374-81. PubMed ID: 15863234
[TBL] [Abstract][Full Text] [Related]
9. Highly potent novel opioid receptor agonist in the 14-alkoxymetopon series.
Fürst Z; Búzás B; Friedmann T; Schmidhammer H; Borsodi A
Eur J Pharmacol; 1993 May; 236(2):209-15. PubMed ID: 8391457
[TBL] [Abstract][Full Text] [Related]
10. Opioid receptor agonist potencies of morphine and morphine-6-glucuronide in the guinea-pig ileum.
Schmidt N; Brune K; Geisslinger G
Eur J Pharmacol; 1994 Apr; 255(1-3):245-7. PubMed ID: 8026550
[TBL] [Abstract][Full Text] [Related]
11. Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine.
Francés B; Gout R; Campistron G; Panconi E; Cros J
Prog Clin Biol Res; 1990; 328():477-80. PubMed ID: 2154808
[TBL] [Abstract][Full Text] [Related]
12. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
Ward SJ; Takemori AE
J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
[TBL] [Abstract][Full Text] [Related]
14. Influence of spatial orientation of the C-6-OH group in ring C of morphine derivatives on opioid activity.
Friedmann T; Tóth Z; Hosztafi S; Simon CS; Makleit S; Fürst S
Arch Int Pharmacodyn Ther; 1994; 328(1):16-25. PubMed ID: 7893188
[TBL] [Abstract][Full Text] [Related]
15. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
[TBL] [Abstract][Full Text] [Related]
16. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
[TBL] [Abstract][Full Text] [Related]
17. 14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes.
Bidlack JM; Frey DK; Seyed-Mozaffari A; Archer S
Biochemistry; 1989 May; 28(10):4333-9. PubMed ID: 2548575
[TBL] [Abstract][Full Text] [Related]
18. Effects of some 7-arylidene and 7-heteroarylidene morphinan-6-ones on the antinociceptive activity of [D-Pen2, D-Pen5]enkephalin and [D-Ala2, Glu4]deltorphin II and on multiple opioid receptors.
Bhargava HN; Zhao GM; Bian JT; Nan Y; Upadhyaya SP; Xu W; Dunn WJ; Bauer L
Peptides; 1997; 18(5):695-701. PubMed ID: 9213363
[TBL] [Abstract][Full Text] [Related]
19. Morphine-6-glucuronide, a potent mu agonist.
Pasternak GW; Bodnar RJ; Clark JA; Inturrisi CE
Life Sci; 1987 Dec; 41(26):2845-9. PubMed ID: 2826951
[TBL] [Abstract][Full Text] [Related]
20. Activity of mu- and delta-selective opioid agonists in the guinea pig ileum preparation: differentiation into peptide and nonpeptide classes with beta-funaltrexamine.
Ward SJ; LoPresti D; James DW
J Pharmacol Exp Ther; 1986 Aug; 238(2):625-31. PubMed ID: 3016244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
